The male god of magic capital

In the evening, Luo Cheng, Li Chaozong, Li Chaoyang and others gathered at the Shangri-La Hotel and ate Quanjude Roast Duck.

Before that, Chengtian Holdings invested 2 million in Quanjude's strategy. At present, the joint venture restaurant between Quanjude Company and Chengtian Catering Company has opened in Shangri-La Hotel.

"This time, the cooperation between American Amgen Company and Zhifei Biotech was prevented. It is really exhausting." Li Chaozong drank fine wine and ate roast duck, with a face full of satisfaction.

"I heard that when Orient Fund was sweeping the market this time, the price was much higher, which caused the cost to be too high and exceeded the budget, so it bought a lot less stocks, resulting in a lot less right to speak in Zhifei Bio. "Li Chaoyang on the side spoke with sarcasm in his tone.

This time, Orient Fund was blocked by Chengtian Private Equity Fund, and there was no stock that could buy Zhifei Biotech at a price below 100 yuan per share.

"Chengtian Private Equity Fund bought 100 billion yuan at a low price, and the stock price rushed to 110 yuan per share. Basically, it wiped out all the selling orders in the market, and rose against the trend. Retail investors who can sell in the market, or financial institutions early I just sold it, and the rest are long-term holdings, it is very difficult for Geng Shizhong to buy enough stocks in the secondary stock market!"

"This time Chengtian Private Equity Fund blocked Dongfang Fund very successfully."

Luo Cheng smiled and said: "It's a pity, it's only worth 100 billion. The stock price has already shot up to a very high level because of Geng Shizhong's big sweepstakes."

When the market closed on Friday yesterday, the stock price rushed to 130 yuan per share, which shows how crazy Geng Shizhong is to sweep goods.

Chengtian Private Equity Fund holds 1 million shares on the books, with a floating profit of 30 billion.

"These 1 million shares will be held for a long time!"

Li Chaozong said with a smile: "Geng Shizhong of Dongfang Fund must have died of anger, and his boss Dong Yunqi couldn't complete the task assigned to him."

"If the Oriental Fortune Group facilitates the cooperation between Zhifei Biological and American Amgen, it will be a big loss for us Fenghua Group."

Fenghua Group is also a major shareholder of Zhifei Biotech, and through Zhifei Biological Company, it has sent a lot of benefits to the subsidiaries of Fenghua Group. Li Zongchao is naturally unwilling to cut off the interests of Fenghua Group when the Oriental Fortune Group wants to cut off the benefits. Chengtian Private Equity Fund holds 6.25% of the shares, and the camp of Fenghua Group has more say on the board of directors. It rejected the proposal of the representative of Oriental Fortune Group to cooperate with Amgen Corporation of the United States.

It is meaningless for the Oriental Fortune Group to continue to acquire the shares of Zhifei Biotech.

Geng Shizhong of Dongfang Fund did nothing for nothing!
Li Zongchao said with certainty that the stocks held by Dongfang Fund are in a huge floating loss. He remembers that Geng Shizhong pulled the stock price of Zhifei Biotech to 190 yuan per share in order to sweep up the goods, and then the stock market plummeted. Frustrated.

It can be said that Orient Fund failed very much this time.

"Mr. Luo, I don't know when the Orient Fund wants to come out this time."

Luo Cheng smiled and said, "Whatever, let Geng Shizhong be trapped!"

"Next, I plan to invest in Hengrui Medicine's stock, and I hope I can get 100 billion in it!"

Hengrui Medicine is the largest research and production base of anti-tumor drugs in China. It is also a medical group spanning multiple fields, with a market value of more than 2000 billion.

The stock market has plummeted recently, and the share price of Hengrui Medicine has also fallen a lot, plummeting from a high of 47 yuan per share to 32 yuan per share.

Chengtian Private Equity Fund invested 100 billion in Zhifei Biology, and now there are still 300 billion funds. Luo Cheng plans to invest another 100 billion in Hengrui Medicine, and then wait for the market to strengthen and the medical sector to strengthen.

"Mr. Luo, I'm just waiting for your words." Li Chaoyang was very excited: "Jiang Chaofei of Guotai Fund also plans to buy Hengrui Medicine, and acquire Sanyuan Gene and Datang Pharmaceutical, two companies that are privately held by them. Corporate blood transfusion!"

Sanyuan Gene and Datang Pharmaceutical are small listed companies, and members of the Bund Trading Club will take advantage of this to make a fortune. Luo Cheng shook his head. He did not expect Jiang Chaofei of Guotai Fund to seek such benefits.

This time Guotai Fund wanted to buy shares in Hengrui Medicine. In Luo Cheng's view, it was not a simple acquisition of Sanyuan Gene. Datang Pharmaceutical, two small listed companies, was as simple as it was, and there was a bigger purpose behind it.

"Mr. Li, I think Guotai Fund has a bigger purpose, not just to acquire Sanyuan Gene, but the two companies, Datang Pharmaceutical, may just be incidental."

Li Chaoyang listened to Luo Cheng's words and fell into deep thought. Their Chaoyang Group is also the major shareholder of Hengrui Medicine, and Guotai Fund plans to join the board of Hengrui Medicine. Rui Medicine's daily management, operation, and realization of benefit transfer, such as letting Hengrui Medicine place orders with Chaoyang Group's subsidiaries, which has gained a lot of benefits. Now that Guotai Fund is involved, he is worried that Guotai Group will also intervene in Hengrui Medicine's business. affairs, damage the interests of Chaoyang Group.

In fact, the relationship between Chaoyang Group and the Bund Trading Club is not good. Chaoyang Financial Management Company was once blocked by members of the Bund Trading Club, which suffered heavy losses and hurt its vitality.

What is the real purpose of Guotai Fund's large purchase of Hengrui Medicine this time?
Guotai Fund had quietly bought shares of Hengrui Medicine in the secondary stock market before, but because of the recent stock market crash, it stopped buying.

"Mr. Luo, I hope Chengtian Private Equity Fund will buy more shares of Hengrui Medicine. When the time comes, we will stand together at the shareholders' meeting and the board of directors!"

Luo Cheng smiled and said, "Naturally!"

His relationship with the Bund Trading Club is getting worse and worse, so he naturally wants to win over the Bund Trading Club's opponents.

The next day, Sunday, Luo Cheng checked the mails submitted by various departments and subsidiaries in the office.

"Boss, Geng Shizhong from Orient Fund called to ask for the market price to buy the shares of Zhifei Biological that we hold!"

"Not for sale!" Luo Cheng refused without thinking.

Until noon.

"Boss, Jiang Chaofei from Guotai Fund also called and wanted to buy the stock of Zhifei Biological in our hands!"

Jiang Chaofei of Guotai Fund also wants to buy Zhifei Biology?
Isn't Jiang Chaofei going to buy Hengrui Medicine?
"Do not sell!"

Luo Cheng also refused.

These 1 million shares of Zhifei Biotech will not be sold, and Luo Cheng will hold them for a long time.

Next is Qianhengrui Medicine.

Luo Cheng must act quickly. Jiang Chaofei of Guotai Fund may buy a large amount of Hengrui Medicine's stock at any time. If the two parties compete in the secondary market, the cost of opening a position will be much higher!

In the afternoon, Luo Cheng came to the trading room and ordered: "Give me a large sum of shares in Hengrui Medicine when the market opens tomorrow!"

"This time, we will not give Guotai Fund a chance to buy!"

"Yes, BOSS" Everyone was excited, like a crocodile opening its mouth wide.

···
At this moment, Guotai Fund, Jiang Chaofei accepted the task of the boss Qin Qihui, asking him to buy enough shares of Hengrui Medicine, Guotai Group is going to enter the pharmaceutical industry.

Jiang Chaofei has another purpose this time, which is to ask for mergers and acquisitions after participating in the daily management of the giant company Hengrui Medicine.
Sanyuan Gene and Datang Pharmaceuticals are two companies.

As a member of the Bund Trading Club, Jiang Chaofei will naturally give some benefits to other big hot money members, and immediately notify Fang Xinyu, Little Crocodile, Zhang Zhihan, Xiao Xinyi and other big hot money.

Then let the four of them operate Sanyuan Gene, the stock of Datang Pharmaceutical, and help him operate his private funds by the way. After all, Jiang Chaofei is now a star manager, and it will be troublesome to engage in insider operations in private and exchange benefits.

So let the little crocodile, Fang Xinyu and the others have big hot money to do it, and his private funds are also directly transferred to the little crocodile, Fang Xinyu and others, let them operate.

Fang Xinyu, Little Crocodile, Zhang Zhihan, and Xiao Xinyi naturally agreed to do it at the opening!

And Jiang Chaofei looked at the stock price chart of Hengrui Medicine, and thought for a while.

"The stock price has to find a way to make it fall below 30 yuan per share quickly. Taking advantage of the continued decline in the market today, it is not a problem for Zhifei Biotech's stock price to fall to 25 yuan per share!"

"I'm opening a short position, drop it!"

"At the moment I happen to have a card in my hand."

At night, Guotai Securities released heavy bad news.

"Two commercial spies of Hengrui Medicine were indicted by the U.S. federal court for divulging trade secrets worth US$5 million to Hengrui Medicine. They copied proprietary information related to diabetes, heart disease and cancer drug research and development to external hard drive, and the two have repeatedly sent emails involving commercial secrets, Hengrui Medicine may be sanctioned!"

Guotai Securities blew up the news, and it exploded immediately!

"I'll go, the stock price of Hengrui Medicine is getting worse."

"The stock price of Hengrui Medicine has been sluggish recently, but now it seems that its stock price will fall below 30 yuan a share."

"I'll go, I'll make a big drop at the opening!"

"Short, short!"

"It will definitely fall below 30 yuan a share, maybe there will be a limit down today!"

"Ham, the limit-down may not be possible, and it is possible to drop to 25 yuan a share."

"Guotai Securities must have shorted Hengrui Medicine, right?"

···
The next day, May 5th, Monday, at 20:8 a.m., there is an hour before the opening.

Jiang Chaofei sneered in his heart: "When the stock market opens, let me smash Hengrui Medicine's stock price down, let it fall to the limit, and then we will sweep the stock!"

He stood with his hands behind his back, on the Guotai Building, overlooking the entire Shanghai!

"Yes, manager!" Everyone was eager to move.

···
Chengtian Holding Company, Luo Cheng saw Guotai Securities' actions, and immediately understood something.

Hehe, releasing such bad news must be an opportunity to smash up the stock price, and then eat up all of it after the stock price plummets.

This Jiang Chaofei really has a brain, playing with the public to applaud!

But Luo Cheng could see through it at a glance!

Immediately, Luo Cheng ordered: "After the opening of the market, buy steadily, not too much, and after the sharp drop is over, buy a lot!"